Glycation end-product cross-link breaker reduces collagen and improves cardiac function in aging diabetic heart. - Wikidata - awgldk - TriplyDB

Glycation end-product cross-link breaker reduces collagen and improves cardiac function in aging diabetic heart.

Glycation end-product cross-link breaker reduces collagen and improves cardiac function in aging diabetic heart.

http://www.wikidata.org/entity/Q44567699

about

The role of glucosamine-induced ER stress in diabetic atherogenesis Diabetic cardiomyopathy: pathophysiology and clinical features Emerging drugs for diabetic retinopathy.Expression and regulation of facilitative glucose transporters in equine insulin-sensitive tissue: from physiology to pathology.Structural arrangement of the cardiac collagen fibers of healthy and diabetic dogs.Assessment of cost and health resource utilization for elderly patients with heart failure and diabetes mellitus Age and the effectiveness of anti-hypertensive therapy on improvement in diastolic function.Screening for left ventricular hypertrophy in patients with type 2 diabetes mellitus in the community.Alagebrium in combination with exercise ameliorates age-associated ventricular and vascular stiffness.Reduced acute vascular injury and atherosclerosis in hyperlipidemic mice transgenic for lysozyme.Diabetic heart disease.Advanced glycation end product cross-linking: pathophysiologic role and therapeutic target in cardiovascular disease.Advanced glycation end products stimulate osteoblast apoptosis via the MAP kinase and cytosolic apoptotic pathways.Association of Metabolic Syndrome with the Cardioankle Vascular Index in Asymptomatic Korean Population.Advanced glycation end product cross-link breaker attenuates diabetes-induced cardiac dysfunction by improving sarcoplasmic reticulum calcium handling.Predictive value of advanced glycation end products for the development of post-infarction heart failure: a preliminary report.The diabetic myocardium.Remodeling of the rat distal colon in diabetes: function and ultrastructure.The impact of diabetes on heart failure: opportunities for intervention.Advanced glycation end-products (AGEs) and heart failure: pathophysiology and clinical implications.Aging and the cardiac collagen matrix: Novel mediators of fibrotic remodelling Cardiac inflammation associated with a Western diet is mediated via activation of RAGE by AGEs.Advanced glycation end products accumulate in vascular smooth muscle and modify vascular but not ventricular properties in elderly hypertensive canines.The receptor for advanced glycation endproducts (RAGE) and cardiovascular disease.Emerging concepts in cardiac matrix biology.Diabetic Cardiomyopathy: An Immunometabolic Perspective.Targeting fibrosis for the treatment of heart failure: a role for transforming growth factor-β.Advanced glycation end products: role in pathology of diabetic cardiomyopathy.Targeting advanced glycation with pharmaceutical agents: where are we now?Atrial Remodeling And Atrial Fibrillation: Mechanistic Interactions And Clinical Implications.Cardioprotective effect of pioglitazone in diabetic and non-diabetic rats subjected to acute myocardial infarction involves suppression of AGE-RAGE axis and inhibition of apoptosis.In vitro model to study the effects of matrix stiffening on Ca2+ handling and myofilament function in isolated adult rat cardiomyocytes.Left ventricular diastolic dysfunction in asymptomatic type 2 diabetic patients: detection and evaluation by tissue Doppler imaging.Advanced glycation end products enhance expression of pro-apoptotic genes and stimulate fibroblast apoptosis through cytoplasmic and mitochondrial pathways.Blockage of receptor for advanced glycation end products prevents development of cardiac dysfunction in db/db type 2 diabetic mice.The presence of fructosamine in human aortic valves is associated with valve stiffness.Impaired left ventricular relaxation in type 2 diabetic rats is related to myocardial accumulation of N(epsilon)-(carboxymethyl) lysine.Left ventricular dysfunction in hypertensive patients with Type 2 diabetes mellitus.C16, a novel advanced glycation endproduct breaker, restores cardiovascular dysfunction in experimental diabetic rats.Phaseolamin treatment prevents oxidative stress and collagen deposition in the hearts of streptozotocin-induced diabetic rats.

P2860

Q26830592-729D5F6B-4011-4E9D-964A-D26FF6C0077B Q30457504-005CC446-1130-4373-88CF-CEFACF4B6344 Q33388498-8AF92568-B0B2-48A3-9840-30C71ECD58EA Q33767041-F3E093DB-897F-4D2F-B061-1C8EF24E2CEA Q33870108-E535584D-5C35-41BF-8EDA-50532A3DA7E9 Q34024171-BCD0FE25-A4D3-4EAA-A8E6-A98AEEA5D477 Q34231421-29E71374-BE51-4996-8B09-5BA3F724F11E Q34980239-80D1EC0B-F2E7-46E4-8D23-F87083E5384F Q35177586-D0DA7F13-725C-4D3D-9F06-189FFD1A8423 Q35221896-D851AAF6-9677-479D-98FA-5B72B023C671 Q35771450-76D381AE-4138-45E4-8558-7B67B386731A Q35796793-2905057A-D9BB-4AD9-AEA9-B7141035B912 Q35878806-7A42356F-3DCD-4811-8B2B-965793D3E1C7 Q35932334-A58A7F66-8CC4-4A95-894A-5747041F2739 Q36193769-125F45C5-A03A-4C35-AD68-375103845837 Q36373255-582ABCF5-105A-4840-9993-7682A89CD469 Q36415838-A4A6BBBB-E205-4A27-BF6F-CA073F4239BA Q36480308-2209D2CC-AE7E-4BC8-BA6E-C9BED3470AED Q36830277-C8A3C4D7-7656-4275-9972-243E6879CDF3 Q37006353-4E9F1CFF-FE2E-4502-BB66-9047B3F4D8D9 Q37096257-DCF66203-87C1-40D3-A909-C1821CD64A04 Q37120232-30BD8021-6B4F-48AA-966C-CAA82A33D16B Q37366116-052DEAF4-F0F4-4D1E-B788-E2642E67B744 Q37412673-0439C65F-2869-4618-9A40-A2EB2ACB5328 Q37661389-1544F819-D480-493B-80F9-626EC18C9B8C Q37741735-72396F89-93BF-4725-A953-3AAA549D582B Q37924999-790B308B-FD7E-43F4-99A2-6B654E150A1C Q38081119-C8BA9597-7F94-4A8D-94AA-C589ED88AAE0 Q38890348-89A40181-9E9B-4B2C-B43A-C8567728BB9B Q39300430-C4AA64BC-65A8-4B0D-84B3-B3E968C652F5 Q39818168-32A2064E-C492-453C-8DC0-D6A950399CA7 Q41011024-80A118E2-F724-4992-8FA7-BC6AB57013BD Q42590841-E7570C59-3E35-4F91-92FE-EA93BA00B45F Q45182285-AECF1D0F-5EA2-4D36-B143-BC6AD828833E Q45979790-EED551E7-40D0-452E-B517-EBF00464BBF5 Q46536538-B61012EE-3AE6-4A23-AAED-F1FD2ABFEB3C Q46639089-816EEFAA-43D3-4C73-9815-D40D426D98F1 Q46657388-A99458C7-17E1-43A7-B1DE-ED8050B12A15 Q46811176-F8C7483B-B48B-42D8-A77C-109A656E2389 Q46929788-A374EFE9-960E-48D8-8F39-1874F3EA6579

P2860

Glycation end-product cross-link breaker reduces collagen and improves cardiac function in aging diabetic heart.

http://www.wikidata.org/entity/Q44567699

description

2003 nî lūn-bûn

@nan

2003年の論文

@ja

2003年学术文章

@wuu

2003年学术文章

@zh

2003年学术文章

@zh-cn

2003年学术文章

@zh-hans

2003年学术文章

@zh-my

2003年学术文章

@zh-sg

2003年學術文章

@yue

2003年學術文章

@zh-hant

name

Glycation end-product cross-li ...... ction in aging diabetic heart.

@en

Glycation end-product cross-li ...... ction in aging diabetic heart.

@nl

type

label

Glycation end-product cross-li ...... ction in aging diabetic heart.

@en

Glycation end-product cross-li ...... ction in aging diabetic heart.

@nl

prefLabel

Glycation end-product cross-li ...... ction in aging diabetic heart.

@en

Glycation end-product cross-li ...... ction in aging diabetic heart.

@nl

P1433

Q44567699-598576DC-C77C-45D1-9670-0E1F31C460BA

P1476

Q44567699-61F353C6-6E97-4C10-A0DA-47D677DBC5D0

P2093

Q44567699-3551D9FA-215E-4A0B-B24C-B861095FA545

Q44567699-4292A79E-44D4-4D0A-8590-FB8C7441675F

Q44567699-80092A2A-4637-4A69-81CC-92C3A672E6DD

Q44567699-8B86685C-CED9-4E4F-ACBD-4693CCCD5DFD

Q44567699-9DFAF47F-5CD7-4FFA-81FA-AE5725CB389D

Q44567699-B21AFC19-9C98-4359-99C1-4592950F4F77

Q44567699-C39B2F49-D9FA-43B8-9192-536FA9756A06

Q44567699-F3FC61BC-4867-4E15-8A16-8FFBA3CC2ECA

P2860

Q44567699-099407C7-57CF-46E4-A54A-1D85C5EBE4B6

Q44567699-09A2824F-3667-4EFD-8616-7F677892434F

Q44567699-0F708461-823B-4FCE-8C46-5DB2FC2DBC77

Q44567699-218CAEB4-3720-4FC6-AC6E-B40E196C36AF

Q44567699-287CEBC9-65DE-4086-B2DF-1B0AEE6E14A7

Q44567699-28A3CA13-B824-4B62-9FA3-990114DDFAE3

Q44567699-3ED2181A-2B39-4870-A352-3A54010FE001

Q44567699-4A1811EA-6162-4F42-B1D9-C8A33C4F7DDA

Q44567699-4F7D0C09-8528-4C01-8ACB-86B2A5121134

Q44567699-682AA9A8-9468-447F-843F-04E27128916D

P304

Q44567699-E192C939-0460-4C48-B393-A1532F192F21

P31

Q44567699-1919A086-60AD-41A7-B6B7-59F8216A15AA

P356

Q44567699-8B8848D4-3D56-4CC4-BA00-3400A758E618

P433

Q44567699-9D852CF9-5BFA-4F87-BB84-5001B837C726

P478

Q44567699-1E5D2CF4-FCA0-49FF-8E1E-38FB64106F21

P577

Q44567699-FE9896AC-1C0C-475B-B527-EC7A87233AE7

P5875

Q44567699-352B490F-0976-4F7E-93FA-9B7BF6BEB112

P698

Q44567699-C2512907-4D0F-4105-B473-1F7BF194B927

P356

AJPHEART.00516.2003

P1433

American Journal of Physiology - Heart and Circulatory Physiology

P1476

Glycation end-product cross-li ...... ction in aging diabetic heart.

@en

P2093

Ashwani Malhotra

http://www.w3.org/2001/XMLSchema#string

Dorothy E Vatner

http://www.w3.org/2001/XMLSchema#string

Garikiparthy N Jyothirmayi

http://www.w3.org/2001/XMLSchema#string

Jing Liu

http://www.w3.org/2001/XMLSchema#string

Leonard G Meggs

http://www.w3.org/2001/XMLSchema#string

Malthi R Masurekar

http://www.w3.org/2001/XMLSchema#string

Stephen F Vatner

http://www.w3.org/2001/XMLSchema#string

Timothy J Regan

http://www.w3.org/2001/XMLSchema#string

P2860

Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage

Blockade of advanced glycation end-product formation restores ischemia-induced angiogenesis in diabetic mice

A cross-link breaker has sustained effects on arterial and ventricular properties in older rhesus monkeys

An advanced glycation endproduct cross-link breaker can reverse age-related increases in myocardial stiffness.

Evidence for cardiomyopathy in familial diabetes mellitus.

Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms.

Determination of hydroxyproline.

Improved arterial compliance by a novel advanced glycation end-product crosslink breaker.

Glycation of collagen: the basis of its central role in the late complications of ageing and diabetes.

Diabetes and cardiovascular disease. The Framingham study.

P304

H2587-91

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1152/AJPHEART.00516.2003

http://www.w3.org/2001/XMLSchema#string

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

285

http://www.w3.org/2001/XMLSchema#string

P577

2003-08-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

10590283

http://www.w3.org/2001/XMLSchema#string

P698

12946933

http://www.w3.org/2001/XMLSchema#string